PYC Therapeutics Replicates Positive Results in Multiple-Dose Phase of Blinding Eye Disease Clinical Trial; Shares Down 8%

PYC Therapeutics在致盲眼病临床试验的多剂段中成功复制了积极结果；股价下跌8%

MT Newswires · 2024/10/22 09:05

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

登录免费看全文

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。更多信息

PYC Therapeutics Replicates Positive Results in Multiple-Dose Phase of Blinding Eye Disease Clinical Trial; Shares Down 8%

PYC Therapeutics Replicates Positive Results in Multiple-Dose Phase of Blinding Eye Disease Clinical Trial; Shares Down 8%

风险及免责提示

声明